CCC
PFE icon

Chesapeake Capital Corp’s Pfizer PFE Stock Holding History

Chesapeake Capital Corp’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$319K Sell
13,236
-6,750
-34% -$177K 0.17% 152
2026
Q1 		$561K Hold
19,986
– – 0.4% 102
2025
Q4 		$498K Buy
+19,986
New +$504K 0.42% 108
2024
Q4 		– Sell
-10,115
Closed -$293K – 188
2024
Q3 		$293K Buy
+10,115
New +$295K 0.27% 150

Other funds holding PFE

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
SLAM
Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Chesapeake Capital Corp's PFE Position: Q2 2026 in Review

Chesapeake Capital Corp reduced its Pfizer (PFE) stake by 34% in Q2 2026, selling an estimated $177K and leaving 13,236 shares worth $319K. The position accounts for 0.17% of the portfolio, ranked #152.

Chesapeake Capital Corp first reported a position in PFE in Q3 2024 and has held it in 4 quarters since. The position peaked at $561K in Q1 2026. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Chesapeake Capital Corp held 13,236 shares of Pfizer worth $319K as of Q2 2026.
  • Chesapeake Capital Corp sold 6,750 Pfizer shares in Q2 2026, an estimated $177K.
  • Pfizer made up 0.17% of Chesapeake Capital Corp's portfolio in Q2 2026, its #152 holding.
  • Chesapeake Capital Corp first reported a position in Pfizer in Q3 2024 and has held it in 4 quarters since.
  • Chesapeake Capital Corp's Pfizer position peaked at $561K in Q1 2026.
  • 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Chesapeake Capital Corp's 13F filing for Q2 2026, filed 29 Jul 2026.